Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Jul 31, 2018 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 14,027 | $24.00 | 238,785 |
Jul 31, 2018 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 14,027 | $26.00 | 224,758 |
Jul 31, 2018 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 14,027 | -- | 224,758 |
Feb 25, 2011 |
President & COO
|
President & COO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 13,576 | -- | 40,118 |
Feb 13, 2017 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 13,409 | $22.57 | 213,740 |
Feb 13, 2017 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 13,409 | $31.51 | 200,331 |
Feb 13, 2017 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 13,409 | -- | -- |
Mar 16, 2015 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 13,125 | -- | 187,339 |
Mar 16, 2014 |
President & CEO
|
President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 13,124 | -- | 172,707 |
Feb 27, 2012 |
President & COO
|
President & COO | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 12,980 | $24.77 | 62,746 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.